Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14837517 | 0.79 | HPGDS (1.00) | HPGDS | |
| SCHEMBL14974541 | 0.74 | HPGDS (0.62) | HPGDS | |
| SCHEMBL740988 | 0.73 | HPGDS (0.58) | HPGDSNPY5R | |
| SCHEMBL14986299 | 0.73 | NPY5R (0.67) | NPY5R | |
| SCHEMBL6921557 | 0.72 | HPGDS (0.56) | HPGDSNPY5R | |
| SCHEMBL652176 | 0.72 | HDAC1 (0.75) | — | |
| SCHEMBL6216499 | 0.71 | NPY5R (1.00) | NPY5R | |
| SCHEMBL761594 | 0.71 | NPY5R (0.56) | HPGDSNPY5R | |
| SCHEMBL740490 | 0.71 | HPGDS (0.55) | HPGDSNPY5R | |
| SCHEMBL14983918 | 0.70 | NPY5R (0.62) | NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2576536-B1 | HAEMATOPOIETIC-PROSTAGLANDIN D2 SYNTHASE INHIBITORS | UNIV QUEENSLAND (AU) | 2016-09-14 | — | — | EP | disclosed |
| US-9199976-B2 | Haematopoietic-prostaglandin D2 synthase inhibitors | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-12-01 | — | — | US | disclosed |
| US-20130137684-A1 | HAEMATOPOIETIC-PROSTAGLANDIN D2 SYNTHASE INHIBITORS | THE UNIVERSITY OF QUEENSLAND (AU) | 2013-05-30 | — | — | US | disclosed |
| US-20130137793-A1 | Construction Coating Compositions And Methods Of Applying The Same | FORMULATED SOLUTIONS LLC (US) | 2013-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130137684-A1 | HAEMATOPOIETIC-PROSTAGLANDIN D2 SYNTHASE INHIBITORS | HPGDS, PTGES, PTGIS | HPGDS 1/4885NPY5R 3070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.